Emergent’s application for its Narcan product to be sold OTC for the treatment of opioid overdose has been accepted by the US FDA and provided priority review.
The company’s Sandoz division is offering 15 generic and OTC medicines to be sold at zero profit to low- and middle-income countries to treat the virus.
The FDA posted a public missive alongside a warning letter to a Chinese OTC drug manufacturer, highlighting the efforts it had been making to address data integrity issues.
Pfizer has announced a major shakeup of its business by splitting into three units: Innovative Medicines, Established Medicines and Consumer Healthcare.
